How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) released its earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.56) by $0.02.

When did Cellect Biotechnology's stock split?

Shares of Cellect Biotechnology split before market open on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly issued shares were payable to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT) , Gilead Sciences (GILD) , Pluristem Therapeutics (PSTI) , NVIDIA (NVDA) , Teva Pharmaceutical Industries (TEVA) , Acasti Pharma (ACST) , Allergan (AGN) , Novavax (NVAX) and RedHill Biopharma (RDHL) .

NASDAQ:APOP

Cellect Biotechnology (APOP) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free APOP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $13.10
▼
$13.37
50-Day Range: $7.54
▼
$13.40
52-Week Range: $6.64
▼
$35.52

Volume: 17,400 shs
Average Volume: 479,845 shs
Market Capitalization: $12.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Cellect Biotechnology alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Cellect Biotechnology Stock (NASDAQ:APOP)

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Ad Manward Press

Can't believe it's happening again

We explain how this event works in full right here.

APOP Stock News Headlines

March 1, 2024 | wsj.com

Krystal Biotech Inc.

June 23, 2023 | bizjournals.com

Raleigh/Durham Biotech News

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

April 19, 2023 | seekingalpha.com

Sana Biotechnology Is Technically Overbought So Buy It Later

April 19, 2023 | cnbc.com

Piper Sandler says this biotech stock can outperform thanks to Alzheimer's treatment

February 23, 2023 | benzinga.com

$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying

January 30, 2023 | finance.yahoo.com

Global Agricultural Biotechnology Market to Reach $88.9 Billion by 2030

November 24, 2022 | morningstar.com

Why These Biotech Stocks Are Outperforming the Market

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

November 16, 2022 | realmoney.thestreet.com

Seeing Good Action in Biotechnology Stocks

September 18, 2022 | fool.co.uk

Investing in Biotech: Top UK Biotech Stocks in 2022

November 4, 2021 | finance.yahoo.com

Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer

November 2, 2021 | finance.yahoo.com

Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia

October 16, 2021 | apnews.com

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with ...

October 15, 2021 | finance.yahoo.com

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals

October 14, 2021 | finanznachrichten.de

Cellect Biotechnology Ltd.: Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals

September 27, 2021 | benzinga.com

Why Cellect Biotechnology Shares Are Rising Today

September 27, 2021 | finance.yahoo.com

Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals

September 3, 2021 | markets.businessinsider.com

Pre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…

September 2, 2021 | finance.yahoo.com

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.

August 24, 2021 | finance.yahoo.com

Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results

August 13, 2021 | apnews.com

The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement ...

August 13, 2021 | finance.yahoo.com

The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals

July 27, 2021 | nasdaq.com

Cellect Biotechnology Ltd. American Depositary Shares (APOP)

See More Headlines

Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/13/2018
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & Medical Instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:APOP
CUSIP: N/A
CIK: 1671502
Web: www.cellect.co
Phone: (729) 974-1444
Fax: 972-9767-8750
Employees: 2,020
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.01
Quick Ratio: 3.01

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.77 per share
Price / Book: 2.76

Miscellaneous

Outstanding Shares: 977,000
Free Float: N/A
Market Cap: $12.87 million
Optionable: Not Optionable
Beta: 1.87

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Shai Yarkoni
Chief Executive Officer & Director
Amos Ofer
Chief Operating Officer
Yaron Ben-Oz
Chief Financial Officer

Key Competitors

View All Competitors

APOP Stock Analysis - Frequently Asked Questions

How were Cellect Biotechnology's earnings last quarter?: Cellect Biotechnology Ltd. (NASDAQ:APOP) released its earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.56) by $0.02.
When did Cellect Biotechnology's stock split?: Shares of Cellect Biotechnology split before market open on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly issued shares were payable to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.
What other stocks do shareholders of Cellect Biotechnology own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

This page (NASDAQ:APOP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cellect Biotechnology (APOP) Stock Price, News & Analysis

About Cellect Biotechnology Stock (NASDAQ:APOP)

APOP Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

APOP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info